methylprednisolone has been researched along with Left Ventricular Hypertrophy in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Saxena, PR; Schoemaker, RG; Van Kerckhoven, R; van Veghel, R | 1 |
| Costero, O; De Alvaro, F; Díaz Rodríguez, C; Gil, F; Martínez-Ara, J; Picazo, ML; Torre, A | 1 |
2 other study(ies) available for methylprednisolone and Left Ventricular Hypertrophy
| Article | Year |
|---|---|
Pharmacological therapy can increase capillary density in post-infarction remodeled rat hearts.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Aspirin; Blood Pressure; Capillaries; Captopril; Coronary Circulation; Glucocorticoids; Heart Rate; Hypertrophy, Left Ventricular; Imidazoles; Male; Methylprednisolone; Myocardial Infarction; Neovascularization, Physiologic; Random Allocation; Rats; Rats, Wistar; Sympatholytics | 2004 |
[Simultaneous presence of antibodies against the glomerular basement membrane and anti-myeloperoxidase antibodies in 2 patients with rapidly progressive glomerulonephritis].
Topics: Aged; Antibodies, Antineutrophil Cytoplasmic; Autoantibodies; Autoantigens; Autoimmune Diseases; Basement Membrane; Biopsy; Combined Modality Therapy; Cyclophosphamide; Disease Progression; Fatal Outcome; Female; Glomerulonephritis; Hemorrhage; Humans; Hypertrophy, Left Ventricular; Immune Complex Diseases; Immunoglobulin G; Immunosuppressive Agents; Kidney Glomerulus; Methylprednisolone; Middle Aged; Peroxidase; Plasmapheresis; Prognosis; Renal Dialysis; Retroperitoneal Space | 2002 |